BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17045165)

  • 1. Visualizing pancreatic beta-cell mass with [11C]DTBZ.
    Simpson NR; Souza F; Witkowski P; Maffei A; Raffo A; Herron A; Kilbourn M; Jurewicz A; Herold K; Liu E; Hardy MA; Van Heertum R; Harris PE
    Nucl Med Biol; 2006 Oct; 33(7):855-64. PubMed ID: 17045165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
    Souza F; Simpson N; Raffo A; Saxena C; Maffei A; Hardy M; Kilbourn M; Goland R; Leibel R; Mann JJ; Van Heertum R; Harris PE
    J Clin Invest; 2006 Jun; 116(6):1506-13. PubMed ID: 16710474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
    Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
    J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.
    Eriksson O; Jahan M; Johnström P; Korsgren O; Sundin A; Halldin C; Johansson L
    Nucl Med Biol; 2010 Apr; 37(3):357-63. PubMed ID: 20346875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
    Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
    Collantes M; Barajas M; Quincoces G; Ramos-Membrive R; Martí-Climent JM; Ecay M; Rodríguez S; Escalada J; Peñuelas I
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):447-455. PubMed ID: 25881691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
    Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
    Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.
    Normandin MD; Petersen KF; Ding YS; Lin SF; Naik S; Fowles K; Skovronsky DM; Herold KC; McCarthy TJ; Calle RA; Carson RE; Treadway JL; Cline GW
    J Nucl Med; 2012 Jun; 53(6):908-16. PubMed ID: 22573821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
    Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
    Fagerholm V; Mikkola KK; Ishizu T; Arponen E; Kauhanen S; Någren K; Solin O; Nuutila P; Haaparanta M
    J Nucl Med; 2010 Sep; 51(9):1439-46. PubMed ID: 20720057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.
    Singhal T; Ding YS; Weinzimmer D; Normandin MD; Labaree D; Ropchan J; Nabulsi N; Lin SF; Skaddan MB; Soeller WC; Huang Y; Carson RE; Treadway JL; Cline GW
    Mol Imaging Biol; 2011 Oct; 13(5):973-84. PubMed ID: 20824509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers.
    Kilbourn MR
    Nucl Med Biol; 2010 Nov; 37(8):869-71. PubMed ID: 21055616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.
    Kumar A; Lo ST; Öz OK; Sun X
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5663-5665. PubMed ID: 25467156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass.
    Inabnet WB; Milone L; Harris P; Durak E; Freeby MJ; Ahmed L; Sebastian M; Lifante JC; Bessler M; Korner J
    Surgery; 2010 Feb; 147(2):303-9. PubMed ID: 19828168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.
    Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E
    Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
    Harris PE; Farwell MD; Ichise M
    Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.